Antiviral Composition and Method for Using the Same

• US 20100330195A1
• Filed: 06/29/2009
• Published: 12/30/2010
• Est. Priority Date: 06/29/2009
• Status: Active Grant

• Current Assignee: Energizer Auto Sales, Inc. (Energizer Holdings, Inc.)
• Original Assignee: Innovasource LLC (Energizer Holdings, Inc.)
• Inventors: Cueman, Glenn Fletcher, Vest, Kenneth Robert, Ramsey, Barnwell Samuel
• Granted Patent: US 8,383,164 B2
• Time in Patent Office: Days
• US Class Current: 424/616
• CPC Class Codes: A01N 2300/00 Combinations or mixtures of active ingredients covered by classes A01N27/00 - A01N65/48 with other active or formulation relevant ingredients, e.g. specific carrier materials or surfactants, covered by classes A01N25/00 - A01N65/48
• CPC Class Codes: A01N 25/02 containing liquids as carriers, diluents or solvents
• CPC Class Codes: A01N 31/08 Oxygen or sulfur directly attached to an aromatic ring system
• CPC Class Codes: A01N 33/12 Quaternary ammonium compounds
• CPC Class Codes: A01N 59/00 Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
• CPC Class Codes: A61P 31/12 Antivirals

Abstract

The present invention provides an antiviral composition and system for using the same, wherein the antiviral composition includes between about 0.1 to about 0.3 wt % of antimicrobial agent such as benzalkoniumchloride, between about 0.1 to about 1 wt % of chlorinated phenol compound, such as parachlorometaxylenol, between about 0.1 to about 3 wt % of hydrogen peroxide, and at least about 60 wt % aqueous solvent.

Claims

1. An antiviral composition comprising:

a) between about 0.1 to about 0.3 wt % of benzalkoniumchloride;

b) between about 0.1 to about 1 wt % of parachlorometaxylenol;

c) between about 0.1 and about 3 wt % of hydrogen peroxide; and

d) at least about 60 wt % aqueous solvent.

3. The antiviral composition according to claim 1, further comprising skin emollients.

2. An antiviral composition comprising:

a) between about 0.1 to about 0.3 wt % of antimicrobial agent;

b) between about 0.1 to about 1 wt % of chlorinated phenol compound;

c) between about 0.1 and about 3 wt % of hydrogen peroxide; and

d) at least about 60 wt % aqueous solvent.

4. The antiviral composition according to claim 2, wherein the chlorinated phenol compound is parachlorometaxylenol.

5. The antiviral composition according to claim 2, wherein the antimicrobial agent is BZK.

6. An antiviral composition, comprising:

a) between about 0.1 to about 0.3 wt % of antibacterial agent;

b) between about 0.1 to 3 wt. % of hydrogen peroxide; and

c) at least about 60 wt % aqueous solvent.

7. The antiviral composition according to claim 6, wherein said antibacterial agent is BZK.

8. The antiviral composition according to claim 6, further comprising skin emollient.

9. The antiviral composition according to claim 6, further comprising between about 0.1 to about 20 wt % of a surfactant.

10. The antiviral composition according to claim 6, wherein said skin emollient comprises between about 0.1 to about 5 wt % of allontoin.

12. The antiviral composition according to claim 10, further comprising between about 0.1 to about 1 wt % of a chlorinated phenol.

13. The antiviral composition according to claim 10, further comprising skin emollients.

14. The antiviral composition according to claim 10, further comprising between about 0.1 to about 20 wt % of a surfactant.

15. The antiviral composition according to claim 10, further comprising between about 0.1 to about 5 wt % of allontoin.

16. The antiviral composition according to claim 10, wherein the chlorinated phenol compound is parachlorometaxylenol.

11. An antiviral composition, comprising:

a) between about 0.1 to about 2 wt % of chlorinated phenol;

b) between about 0.1 to about 3 wt % of hydrogen peroxide; and

c) at least about 60 wt % aqueous solvent.

17. A method of treating a virus, comprising:

a. applying an antiviral composition to an individual'"'"'s hands, comprising;

(1) between about 0.1 to about 0.3 wt % of benzalkoniumchloride;

(2) between about 0.1 and about 1 wt % of parachlorometaxylenol;

(3) between about 0.1 to about 3 wt % of hydrogen peroxide; and

(4) at least about 60 wt % aqueous solvent; and

b. repeating the administration of the antiviral composition to the hands when needed.

18. The method according to claim 17, wherein the antiviral composition further comprises a skin emollient.

19. The method according to claim 18, wherein said skin emollient comprises from about 0.1 to about 5 wt % allontoin.

20. The method according to claim 17, wherein the antiviral composition further comprises between about 0.1 and about 20 wt % of surfactant.